AI assistant
Sending…
Arctic Bioscience — Director's Dealing 2021
Feb 26, 2021
3536_dirs_2021-02-26_37b2a162-6100-4ee3-9a93-8192d69bcee4.html
Director's Dealing
Open in viewerOpens in your device viewer
Mandatory Notification of Trade by Close Associate of Primary Insider
Mandatory Notification of Trade by Close Associate of Primary Insider
Ajea Invest AS, a company owned 100% by board member in Arctic Bioscience AS, Asbjørn Solevågseide, has on 25 February 2021 acquired 17,500 shares in Arctic Bioscience AS. The shares were acquired at Euronext Growth Oslo at a price of NOK 28,4405 per share.
After this transaction, Ajea Invest AS holds 275,564 Shares in Arctic Bioscience AS directly, and 12.8% of the share capital in PIR IV Invest AS, which holds 2,188,250 Shares in the Company.
More from Arctic Bioscience
Proxy Solicitation & Information Statement
2026
May 13
Proxy Solicitation & Information Statement
2026
May 13
Proxy Solicitation & Information Statement
2026
May 13
Proxy Solicitation & Information Statement
2026
May 13
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7